James S Goydos

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 18, 2018
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.

Janice M Mehnert, Ann W Silk, J H Lee

Pageof 1

Frequent Collaborators

1 joint publications

Janice M Mehnert